BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7579311)

  • 1. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage.
    Romanus V; Hallander HO; Wåhlén P; Olinder-Nielsen AM; Magnusson PH; Juhlin I
    Tuber Lung Dis; 1995 Aug; 76(4):300-10. PubMed ID: 7579311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
    Kontturi A; Soini H; Ollgren J; Salo E
    Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood.
    Katila ML; Brander E; Backman A
    Tubercle; 1987 Dec; 68(4):291-6. PubMed ID: 3138802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.
    Romanus V; Svensson A; Hallander HO
    Tuber Lung Dis; 1992 Jun; 73(3):150-61. PubMed ID: 1421348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn.
    Romanus V
    Tubercle; 1983 Jun; 64(2):101-10. PubMed ID: 6604357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective BCG vaccination in a country with low incidence of tuberculosis.
    Romanus V
    Euro Surveill; 2006; 11(3):14-7. PubMed ID: 16567880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial infections in Sweden.
    Romanus V
    Scand J Infect Dis Suppl; 1995; 98():15-6. PubMed ID: 8867171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1994 Oct; 75(5):348-52. PubMed ID: 7841428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis.
    Zimmermann P; Finn A; Curtis N
    J Infect Dis; 2018 Jul; 218(5):679-687. PubMed ID: 29635431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden.
    Romanus V; Fasth A; Tordai P; Wiholm BE
    Acta Paediatr; 1993 Dec; 82(12):1043-52. PubMed ID: 8155923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria.
    Strannegård IL; Larsson LO; Wennergren G; Strannegård O
    Allergy; 1998 Mar; 53(3):249-54. PubMed ID: 9542604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical mycobacterial lymphadenitis in Swedish children during the post-BCG vaccination era.
    Petrini B; Bennet R
    Acta Paediatr; 2007 Jan; 96(1):146-7. PubMed ID: 17187627
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the incidence of AIDS-associated Mycobacterium avium-intracellulare disease affected by previous exposure to BCG, M. tuberculosis or environmental mycobacteria?
    Grange JM
    Tuber Lung Dis; 1994 Jun; 75(3):234-6. PubMed ID: 7919318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LYMPH GLAND PROCESSES CAUSED BY ATYPICAL MYCOBACTERIA AND MYCOBACTERIUM AVIUM. BACTERIOLOGICALLY VERIFIED CASES IN DENMARK FROM 1935 TO 1961.
    ENGBAEK HC
    Acta Tuberc Pneumol Scand; 1964; 44():108-37. PubMed ID: 14165365
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).
    Portaels F; Aguiar J; Debacker M; Steunou C; Zinsou C; Guédénon A; Meyers WM
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1389-91. PubMed ID: 12414782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.
    Blanc P; Dutronc H; Peuchant O; Dauchy FA; Cazanave C; Neau D; Wirth G; Pellegrin JL; Morlat P; Mercié P; Tunon-de-Lara JM; Doutre MS; Pélissier P; Dupon M
    PLoS One; 2016; 11(12):e0168290. PubMed ID: 27959960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.
    Padungchan S; Konjanart S; Kasiratta S; Daramas S; ten Dam HG
    Bull World Health Organ; 1986; 64(2):247-58. PubMed ID: 3488839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
    Narayanan PR
    Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous mycobacterial cervicofacial adenitis in children: epidemiologic study.
    Tremblay V; Ayad T; Lapointe A; Giguàre C; Quintal MC; Arcand P; Abela A
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):616-22. PubMed ID: 19128665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.